BSE filing, NSE: CHEMCRUX. Summary written from the filing by ALFA Finder's alert engine.
Chemcrux Enterprises Ltd: key numbers
- Share price
- ₹82.30
- Market cap
- ₹121.9 Cr
- Revenue (annual)
- ₹80.65 Cr
- Net profit (annual)
- ₹3.73 Cr
- P/E (TTM)
- 29.4×Sector 34.5×
- Promoter holding
- 72.92%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemcrux Enterprises Ltd
All →Chemcrux Enterprises Other Announcement
Chemcrux Enterprises Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This disclosure provides details on the company's equity structure and stakeholder ownership.
Chemcrux Enterprises Management Change
Chemcrux Enterprises Ltd regularised the appointment of Ms. Zarna Pankaj Thakar as an Independent Director for one year, effective August 4, 2026, per AGM approval.
Chemcrux Enterprises Annual General Meeting
Chemcrux Enterprises held its 30th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement approval and dividend declaration.
Chemcrux Enterprises Management Change
Mr. Bhanubhai Patel and Mr. Shailesh Patel have ceased to be Independent Directors of the Company following the completion of their second five-year tenure.
Chemcrux Enterprises Dividend
Chemcrux Enterprises Limited recommended a final dividend of Re. 1 per equity share for FY 2025-26. The payment follows the upcoming General Meeting.
Chemcrux Enterprises Other Announcement
Chemcrux Enterprises has fixed 10th September 2026 as the record date to ascertain eligibility for the final dividend to be declared at the 30th AGM.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.